Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir vs lamivudine prophylaxis during chemotherapy in hepatitis B–infected patients with malignancy
KCT0000417Phase 3Recruiting
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of entecavir, lamivudine in hepatitis B (HBV), sponsored by Seoul National University Bundang Hospital. Started Apr 2012; status: recruiting.
02
Drugs
entecavirlamivudine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on KCT0000417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000417.